Diagnostic dilemma in CNS vasculitis: a case of primary angiitis of central nervous system mimicking anti-neutrophilic cytoplasmic antibody-associated vasculitis
DOI:
https://doi.org/10.18203/2349-3933.ijam20253354Keywords:
CNS vasculitis, ANCA associated vasculitis, PACNS, CyclophosphamideAbstract
Authors present a diagnostically challenging case of Central Nervous System (CNS) vasculitis presenting with aphasia, confusion, and right-sided weakness due to cerebral vascular accident, initially suspected to be Anti-Neutrophilic Cytoplasmic Antibody (ANCA)-associated vasculitis due to elevated PR3 ANCA titers. The work up for lupus and anti-phospholipid antibodies was negative. Magnetic Resonance Imaging of brain demonstrated abnormal T2 FLAIR and diffusion-weighted imaging with patchy, enhancing lesions, progression of middle cerebral artery involvement, and subacute infarcts in the left parietal and occipital lobes. He responded to Intravenous methylprednisolone followed by oral prednisone and Rituximab infusions every 6 months. Inspite of this, his disease progressed as he developed recurrent headaches, transient ischemic attacks, seizures, paranoia, altered mental status, and agitation. His repeat ANCA test came back negative. Due to the absence of systemic features and subsequent negative ANCA result, his diagnosis was revised to Primary Angiitis of the CNS (PACNS). Treatment with daily oral cyclophosphamide in a dose of 2 mg per kg body weight resulted in disease stabilization and clinical improvement.
Metrics
References
Sherri A, Mortada MM, Makowska J. Primary angiitis of the CNS and ANCA-associated vasculitis: from pathology to treatment. Rheumatol Int. 2024;44:211–22. DOI: https://doi.org/10.1007/s00296-023-05461-9
Esposito D, Trimpou P, Giugliano D. Pituitary dysfunction in granulomatosis with polyangiitis. Pituitary. 2017;20:594–601. DOI: https://doi.org/10.1007/s11102-017-0811-0
Shimojima Y, Kishida D, Ichikawa T. Hypertrophic pachymeningitis in ANCA-associated vasculitis: a cross-sectional and multi-institutional study in Japan (J-CANVAS). Arthritis Res Ther. 2022;24:204. DOI: https://doi.org/10.1186/s13075-022-02898-4
Salvarani C, Brown RD Jr, Calamia KT. Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol. 2007;62:442-51. DOI: https://doi.org/10.1002/ana.21226
Calabrese LH, Duna GF, Lie JT. Vasculitis in the central nervous system. Arthritis Rheum. 1997;40:1189-201. DOI: https://doi.org/10.1002/art.2
Hajj-Ali RA, Calabrese LH. Primary angiitis of the central nervous system. Autoimmun Rev. 2013;12:463-6. DOI: https://doi.org/10.1016/j.autrev.2012.08.004
Salvarani C, Hunder GG, Brown RD. Primary central nervous system vasculitis. N Engl J Med. 2024;391:1028–37. DOI: https://doi.org/10.1056/NEJMra2314942
Kadkhodayan Y, Alreshaid A, Moran CJ. Primary angiitis of the central nervous system at conventional angiography. Radiology. 2004;233:878-82. DOI: https://doi.org/10.1148/radiol.2333031621
Hajj-Ali RA, Calabrese LH. Diagnosis and classification of central nervous system vasculitis. Autoimmun. 2014;48:149-52. DOI: https://doi.org/10.1016/j.jaut.2014.01.007
Salvarani C, Brown RD, Huston J. Treatment of primary CNS vasculitis with rituximab: case report. Neurology. 2014;82:1287-8. DOI: https://doi.org/10.1212/WNL.0000000000000293
Das S, Goswami RP, Sinha D. Mycophenolate mofetil as induction and maintenance immunosuppressive therapy in adult primary central nervous system vasculitis: a prospective observational study. Clin Rheumatol. 2023;42:2155-62. DOI: https://doi.org/10.1007/s10067-023-06602-y